Real-world effectiveness of ustekinumab versus anti-TNF or vedolizumab in ulcerative colitis: induction and 12-month maintenance results from the prospective, observational RUN-UC study
In the prospective RUN-UC study with PS-weighted groups, UST showed higher treatment persistence but no significant difference in maintenance effectiveness compared to anti-TNF or VDZ in UC.
Authors
- Wolfgang Mohl (ORCID: https://orcid.org/0000-0002-3284-211X)
- Matthias Kahl
- Leo Trentmann
- Sandra Plachta‐Danielzik (ORCID: https://orcid.org/0000-0002-1945-4198)
- Robert Ehehalt (ORCID: https://orcid.org/0000-0003-4252-5801)
- Philipp Efken
- Thomas Krause (ORCID: https://orcid.org/0000-0003-4912-1703)
- Andreas Lügering
- Stefanie Howaldt (ORCID: https://orcid.org/0000-0001-9830-9126)
- Bernd Bokemeyer (ORCID: https://orcid.org/0000-0003-2016-6991)
- Stefan Schreiber (ORCID: https://orcid.org/0000-0003-2254-7771)
- Christoph Jochum (ORCID: https://orcid.org/0000-0001-8460-6912)
- Petra Hartmann (ORCID: https://orcid.org/0000-0002-4746-9792)
- Elisabeth Schnoy (ORCID: https://orcid.org/0009-0005-7987-9517)
- Elena Gilman
Institutions
- University of Kassel (DE)
- Kielce University of Technology (PL)
- University Hospital Augsburg (DE)
- University Hospital Heidelberg (DE)
- Hochschule für Angewandte Wissenschaften Kiel (DE)
- Christian-Albrechts-Universität zu Kiel (DE)
- University Hospital Münster (DE)
- University Hospital Schleswig-Holstein (DE)
- IS practice (BE)
- Hamburg Institut (Germany) (DE)
- Crohn's and Colitis UK (GB)
- Klinikum Kassel (DE)
- Klinikum Bremen-Mitte (DE)
- Klinikum Saarbrücken (DE)
- Hamburg Institute for Therapy Research (DE)
- Johannes Wesling Klinikum Minden (DE)
- Clinical Research Center Kiel (DE)
- Charité - Universitätsmedizin Berlin (DE)
- University of Lübeck (DE)
Publication Details
- Journal
- Journal of Crohn s and Colitis
- Published
- 2025-03-27
- DOI
- https://doi.org/10.1093/ecco-jcc/jjaf052
- Citations
- 2
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 3.63